| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/22/2007 | US7220853 Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1 |
| 05/22/2007 | US7220849 Chimeric nucleic acid containing a nucleic acid sequence encoding a propeptide fused to a nucleic acid sequence encoding a vitamin-k dependent protein selected from factor X, factor VII, factor IX, protein C and prothrombin |
| 05/22/2007 | US7220834 FHIT proteins and nucleic acids and methods based thereon |
| 05/22/2007 | US7220728 Administering by topical or lavage administration to mucosal tissue nucleic acid molecule that comprises a nucleotide sequence that either encodes a desired peptide or protein |
| 05/22/2007 | US7220722 Lipoprotein-regulating medicants |
| 05/22/2007 | US7220719 Using recombinant zinc finger proteins; use in human therapeutic applications such as cancer therapy and altering plant phenotypes, including disease resistance, fruit ripening |
| 05/22/2007 | US7220718 Oral treatment of hemophilia |
| 05/22/2007 | US7220717 Administering formulation comprising polypeptide and muteins; For immunoregulation and/or treatment of inflammation; muteins, |
| 05/22/2007 | US7220583 Pseudomonas avr and hop proteins, their encoding nucleic acids, and use thereof |
| 05/22/2007 | US7220577 Modified AAV |
| 05/22/2007 | US7220569 Nucleic acids encoding factor X analogues having a modified protease cleavage site |
| 05/22/2007 | US7220557 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders |
| 05/22/2007 | US7220418 Delivery of trefoil peptides |
| 05/22/2007 | US7220412 Method of preparing an undifferentiated cell |
| 05/22/2007 | US7220400 Delivering a biopolymer to a cell by forming a complex of a biologically active polymer and a cyclic amidinium-containing compound and associating the complex with the cell. |
| 05/22/2007 | CA2242562C Human dnase resistant to actin inhibition |
| 05/18/2007 | WO2007056760A2 Hcv-reactive t cell receptors |
| 05/18/2007 | WO2007056614A1 Gene therapy for renal failure |
| 05/18/2007 | WO2007056543A2 Relaxase modulators and methods of using same |
| 05/18/2007 | WO2007056510A2 Chloride transport upregulation for the treatment of traumatic brain injury |
| 05/18/2007 | WO2007056466A2 Immunosuppression compound and treatment method |
| 05/18/2007 | WO2007056331A2 Compositions and methods for inhibiting expression of factor v leiden mutant gene |
| 05/18/2007 | WO2007056326A2 Compositions and methods for inhibiting expression of nav1.8 gene |
| 05/18/2007 | WO2007056266A2 Cd40 ligand fusion protein vaccine |
| 05/18/2007 | WO2007056039A2 Therapies for seizure disorders using rlip76 |
| 05/18/2007 | WO2007055982A2 Therapies for the regulation of insulin and glucose using rlip76 |
| 05/18/2007 | WO2007055966A2 Therapies for cancer using rlip76 |
| 05/18/2007 | WO2007055704A2 Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides |
| 05/18/2007 | WO2007055682A2 Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides |
| 05/18/2007 | WO2007055561A1 R-ras activity in vascular regulation |
| 05/18/2007 | WO2007055260A1 Material for detection or quantification of human immunodeficiency virus-1 gene, detection or quantification method, gene fragment for therapy, and therapeutic method |
| 05/18/2007 | WO2007055224A1 Therapeutic agent for corneal disease |
| 05/18/2007 | WO2007054250A1 Recombinant expression of multiprotein complexes using polygenes |
| 05/18/2007 | WO2007053956A1 Cancer antigen mage-a9 and uses thereof |
| 05/18/2007 | WO2006103118A3 Therapeutic use of scin, a staphylococcal complement inhibitor in inflammatory diseases |
| 05/18/2007 | WO2006018836A3 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
| 05/18/2007 | WO2005062958A3 Meth0ds of using hcn genes to treat cardiac arrhythmias |
| 05/18/2007 | WO2003076594A3 Genomic screen for epigenetically silenced tumor suppressor genes |
| 05/18/2007 | WO2000040740A3 Gene therapy to promote angiogenesis |
| 05/18/2007 | CA2630023A1 Cancer antigen mage-a9 and uses thereof |
| 05/18/2007 | CA2629522A1 Gene therapy for renal failure |
| 05/18/2007 | CA2628876A1 R-ras activity in vascular regulation |
| 05/18/2007 | CA2628306A1 Immunostimulatory oligonucleotide-based compounds with glycerol-linked dinucleotides and modified guanosines at cpg and uses thereof |
| 05/18/2007 | CA2626891A1 Recombinant expression of multiprotein complexes using polygenes |
| 05/18/2007 | CA2626690A1 Compositions and methods for inhibiting expression of factor v leiden mutant gene |
| 05/18/2007 | CA2626584A1 Compositions and methods for inhibiting expression of nav1.8 gene |
| 05/17/2007 | US20070112176 Lipid membrane structure containing anti-mt-mmp monoclonal antibody |
| 05/17/2007 | US20070111963 Modulation of gene expression by oligomers targeted to chromosomal DNA |
| 05/17/2007 | US20070111962 Immunosuppression compound and treatment method |
| 05/17/2007 | US20070111961 Dbait and uses thereof |
| 05/17/2007 | US20070111959 Combination gene for use in inhibiting cancerous cell growth |
| 05/17/2007 | US20070111958 Antisense IL-4 inhibits viral replication in the liver, lungs, spleen, and even the lymph nodes; can be used in combination with other antiretroviral agents or vaccines |
| 05/17/2007 | US20070111957 Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof |
| 05/17/2007 | US20070111946 Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP) |
| 05/17/2007 | US20070111933 Diagnosis and treatment methods related to aging, especially of liver |
| 05/17/2007 | US20070111929 Methods for the treatment of anxiety and for identification of anxiolytic agents |
| 05/17/2007 | US20070111285 Human skeletal muscle-specific ubiquitin-conjugating emzyme |
| 05/17/2007 | US20070111280 Compositions and methods for non-targeted activation of endogenous genes |
| 05/17/2007 | US20070111228 RNA interference |
| 05/17/2007 | US20070111222 Nucleic acid aptamer-based compositions and methods |
| 05/17/2007 | US20070111221 Method of preparation for pharmaceutical grade plasmid DNA |
| 05/17/2007 | US20070110786 Medical articles having enhanced therapeutic agent binding |
| 05/17/2007 | US20070110772 polypeptide induces production of antibodies against protein on surface of zygotes to prevent infection of malaria from mosquito |
| 05/17/2007 | US20070110769 Clostridial toxin derivatives and methods for treating pain |
| 05/17/2007 | US20070110767 An immunogenic mixture of a vector that contains and expresses in vivo in a porcine host cell and a nucleic acid molecule or fragment thereof encoding a porcine circovirus type B antigen |
| 05/17/2007 | US20070110752 Fibroblast growth factor receptors and methods for their use |
| 05/17/2007 | US20070110749 Centrosome proteins and uses thereof |
| 05/17/2007 | US20070110744 Lymphatic and blood endothelial cell genes |
| 05/17/2007 | US20070110742 Recombinant peptide vector comprising the gene for treatment for autoimmune diseases |
| 05/17/2007 | US20070110736 Mixture comprising mannitol for suspending animal or human cells and for dissolving biologically active molecules in order to introduce molecules into cells using electric current |
| 05/17/2007 | US20070110735 administering to the heart of subject in need of increased capillary density in the heart a trk receptor ligand in an amount effective to increase capillary density in the heart, said trk receptor ligand being selected from the group consisting of brain-derived neurotrophic factor, NT-3, and NT-4. |
| 05/17/2007 | US20070110734 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs |
| 05/17/2007 | US20070110733 Compositions and methods for stem cell delivery |
| 05/17/2007 | US20070110724 DNA viral plasmid for use as gene transfer tool in genetic engineering and genic therapy; improved exogenous transcriptional expression |
| 05/17/2007 | US20070110723 Delivery of trefoil peptides |
| 05/17/2007 | US20070110722 Methods and compositions for the Synthesis of RNA and DNA |
| 05/17/2007 | US20070110721 Plasmid maintenance |
| 05/17/2007 | US20070110720 Vectors, mutant viruses and methods for generating mutant viruses |
| 05/17/2007 | US20070110719 Novel use of adenoviruses and nucleic acids that code for said viruses |
| 05/17/2007 | US20070110718 System for treating and preventing breast cancer |
| 05/17/2007 | US20070110717 Dna vaccines against tumor growth and methods of use thereof |
| 05/17/2007 | US20070110716 Relationship of a specific metabolite to insulin resistance |
| 05/17/2007 | US20070110712 Method of modulating fertility in animals |
| 05/17/2007 | US20070110709 Water-soluble stabilized self-assembled polyelectrolytes |
| 05/17/2007 | US20070110698 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 05/17/2007 | US20070110674 Sono-active liposomes and lipid particles and use thereof as contrast agents and active-agent delivery systems |
| 05/17/2007 | US20070110668 Modulation of Immunity and Ceacam1 Activity |
| 05/16/2007 | EP1785488A1 Adenoviral vectors with two separate expression cassettes |
| 05/16/2007 | EP1785486A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 05/16/2007 | EP1785484A1 Oligonucleotide inhibiting tumor cell proliferation and method therefor |
| 05/16/2007 | EP1785433A1 Viral particle-like construct and method of forming the same under physiological conditions |
| 05/16/2007 | EP1784492A2 Multiple rna polymerase iii promoter expression constructs |
| 05/16/2007 | EP1784217A1 Treatment of hiv infection by t-cell modulation |
| 05/16/2007 | EP1784208A2 Use of a dna molecule as vaccine adjuvant |
| 05/16/2007 | EP1536807A4 Non-polymeric hematopoietic cell clots for delivery of active agents |
| 05/16/2007 | EP1487981B1 Growth regulating proteins |
| 05/16/2007 | EP1355928B1 Universal carrier for targeting molecules to gb3 receptor expressing cells |
| 05/16/2007 | EP1165603B1 Human neurogenin 3-encoding nucleotide sequences |
| 05/16/2007 | EP1147188B1 Internal ribosome entry site (ires), vector containing same and the uses thereof |
| 05/16/2007 | EP1127150B1 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |